Literature DB >> 2783574

Hematologic abnormalities of the immunodeficient mouse mutant, viable motheaten (mev).

G Van Zant1, L Shultz.   

Abstract

We have studied the hematopoietic system of the immunodeficient mouse mutant, viable motheaten (mev/mev). These mice usually die by 9 weeks of age from severe pneumonitis. The lungs at that time are infiltrated with granulocytes, macrophages, and lymphocytes. Granulocyte and macrophage precursor cells (CFU-GM) are dramatically increased in the spleens of mev/mev mice, whereas the bone marrow population of these precursors is decreased when compared with littermate control animals. The CFU-GM population retained its normal dependence on granulocyte-macrophage colony-stimulating factor (GM-CSF) for proliferation and differentiation. In contrast, the frequency of an erythroid precursor (CFU-E) was dramatically increased in spleen and showed increased sensitivity to erythropoietin (Epo). Moreover, a splenic CFU-E subpopulation formed normally appearing erythroid colonies in the absence of exogenous Epo. The bone marrow CFU-E population was significantly diminished in size when compared with either wildtype C57BL/6J mice or mice heterozygous for the mev allele. Unlike the CFU-E population, erythroid burst-forming unit (BFU-E) frequency in mev/mev mice was diminished both in bone marrow and in spleen, although the total number of splenic BFU-E was increased because of splenomegaly in these animals. BFU-E retained their dependence on the presence of both Epo and a source of interleukin 3 (IL-3) for proliferation and differentiation into erythroid bursts. Spleen cells from mev/mev mice, when stimulated in vitro with pokeweed mitogen, failed to produce significant quantities of IL-3. Comparison with medium or +/mev heterozygotes revealed that mev/mev spleen cell-conditioned medium showed a 40-fold reduction in burst-promoting activity. Thus, in viable motheaten mice, there is a major shift in hematopoiesis from bone marrow to spleen, which is accompanied by a diminished capacity of spleen cells to produce burst-promoting activity. These data and those from other studies suggest that the hematopoietic microenvironment of marrow may be impaired in this mutant.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2783574

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  18 in total

1.  Mouse model of congenital polycythemia: Homologous replacement of murine gene by mutant human erythropoietin receptor gene.

Authors:  V Divoky; Z Liu; T M Ryan; J F Prchal; T M Townes; J T Prchal
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

2.  Effects of granulocyte/macrophage colony-stimulating factor on the development and differentiation of CD5-positive macrophages and their potential derivation from a CD5-positive B-cell lineage in mice.

Authors:  K Takahashi; K Miyakawa; A A Wynn; K Nakayama; Y Y Myint; M Naito; L D Shultz; A Tominaga; K Takatsu
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

3.  Deficiency of SHP-1 protein-tyrosine phosphatase activity results in heightened osteoclast function and decreased bone density.

Authors:  S Umeda; W G Beamer; K Takagi; M Naito; S Hayashi; H Yonemitsu; T Yi; L D Shultz
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

Review 4.  Investigations into the regulation and function of the SH2 domain-containing protein-tyrosine phosphatase, SHP-1.

Authors:  Florence W L Tsui; Alberto Martin; John Wang; Hing Wo Tsui
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

5.  Spontaneous insertion of a b2 element in the ptpn6 gene drives a systemic autoinflammatory disease in mice resembling neutrophilic dermatosis in humans.

Authors:  Andrew B Nesterovitch; Sandor Szanto; Andrea Gonda; Tamas Bardos; Katalin Kis-Toth; Vyacheslav A Adarichev; Katalin Olasz; Sheida Ghassemi-Najad; Mark D Hoffman; Michael D Tharp; Katalin Mikecz; Tibor T Glant
Journal:  Am J Pathol       Date:  2011-04       Impact factor: 4.307

6.  Role of the protein tyrosine phosphatase SHP-1 (Src homology phosphatase-1) in the regulation of interleukin-3-induced survival, proliferation and signalling.

Authors:  Nicholas R D Paling; Melanie J Welham
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

Review 7.  Advances in understanding the pathogenesis of primary familial and congenital polycythaemia.

Authors:  Lily J Huang; Yu-Min Shen; Gamze B Bulut
Journal:  Br J Haematol       Date:  2010-01-20       Impact factor: 6.998

8.  Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia.

Authors:  M L McLemore; J Poursine-Laurent; D C Link
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

Review 9.  Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.

Authors:  Nicole Rainville; Edward Jachimowicz; Don M Wojchowski
Journal:  Expert Opin Ther Targets       Date:  2015-09-30       Impact factor: 6.902

Review 10.  The role and target potential of protein tyrosine phosphatases in cancer.

Authors:  Taolin Yi; Daniel Lindner
Journal:  Curr Oncol Rep       Date:  2008-03       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.